Mumps Cases Reach Epidemic Level in Iowa

By MELANIE S. WELTE, Associated Press Writer 42 minutes ago

DES MOINES, Iowa - A mumps epidemic is sweeping across Iowa in the nation's
biggest outbreak in at least 17 years, baffling health officials and worrying
parents.

As of Thursday, 245 confirmed, probable or suspected cases of mumps had been
reported to the Iowa Department of Public Health since mid-January.

The federal Centers for Disease Control and Prevention said it is the nation's
only outbreak, which the
CDC defines as five or more cases in a concentrated area.

"We are calling this an epidemic," said Iowa state epidemiologist Dr. Patricia
Quinlisk, explaining that mumps has spread to more than one-third of the state
and does not appear to be confined to certain age groups or other sectors of the
population.

Quinlisk said Iowa has had about five cases of mumps a year in recent years, and
this is its first large outbreak in nearly 20 years.

"We're trying to figure out why is it happening, why is it happening in Iowa and
why is it happening right now. We don't know," she said.

CDC spokeswoman Lola Russell said the federal agency has no answers yet. But
Quinlisk said one theory is that the infection was brought over from England —
perhaps by a college student — because the strain seen in Iowa has been
identified by the CDC as the same one that has caused tens of thousands of cases
of the mumps in a major outbreak in Britain over the past two years.

"It may have been a college student, since we did see the first activities on
college campuses, but we can't prove that," Quinlisk said. The Public Health
Department said 23 percent of the 245 reported patients are in college.

The CDC said it is the nation's biggest epidemic of mumps since 269 cases were
reported in Douglas County, Kan., from October 1988 to April 1989.

Mumps is a viral infection of the salivary glands. Symptoms include fever,
headache, muscle aches and swelling of the glands close to the jaw. It can cause
serious complications, including meningitis, damage to the testicles and
deafness.

A mumps vaccine was introduced in 1967. Iowa law requires schoolchildren to be
vaccinated against measles and rubella, and the mumps vaccine is included in the
same shot. The state's last major outbreak was in 1987, when 476 people were
infected.

Of the 245 patients this year, at least 66 percent had had the recommended
two-shot vaccination, while 14 percent had received one dose, the Public Health
Department said.

"The vaccine is working," Quinlisk said. "The vaccine certainly was made to
cover this particular strain, because it's a fairly common strain of mumps."
Quinlisk said the vaccine overall is considered about 95 percent effective.

Quinlisk said the mumps outbreak started in eastern Iowa and is spreading
statewide and possibly into the neighboring states of Illinois, Minnesota and
Nebraska. Those states may have one or two cases, she said.

When 11-year-old Will Hean of Davenport starting feeling sick in mid-January,
his family thought he had a bad case of the flu. But his face and throat swelled
and his temperature climbed to 103. His parents took him to the doctor, and he
was diagnosed to their surprise with full-blown mumps.

About two weeks later, the Heans' daughter, Kate, 21, came down with the mumps,
too.

Both children had gotten the measles, mumps and rubella vaccine, or MMR. So had
their other son, 13-year-old Jimmy, who did not get the mumps.

"He had all the shots and everything. You don't think you're going to get the
mumps after you've been inoculated," said Will's father, Wayne Hean.

http://news.yahoo.com/s/ap/mumps_outbreak

I had same problem.
I started with Steriod injection every two weeks but
it turn crazy then switch to Androgel 1% gel rub on
stomach every day but two years later, it turn low
testestone then switch to Testim 1% rub over shoulder
every day. so my testoserone is normal range now.
that why you feel no energy and despress because of
low testosterno that common along with HIVers.
Mark

--- Richard Weber <travelchiko05@...> wrote:

> Now what?  Talked to Primary Doc, he is sending me
> to Endo doc.  What
> does he do, or what will it mean for me?
>
> Really confused on this one and all I want is my
> energy and libido
> back!!!!
>
> Thanks
>
> Rick
>
>
>
>
>
>


Mark

I have been positive for 24 months, and am 37 years old.
Last week my sking biopsy came back positive for KS. Starting tomorrow
I take Kaletra and Epzicom everyday. has anyone taken these before?
Side effects?

HIV "shorts out" many signaling systems in the body, including the
system that signals when testosterone should be made.

Testim gel applied daily is the most natural replacement until a
solution is found for this problem. It contains a trans-dermal
transport molecule to deliver most of the testosterone in the first few
hours.

I use Testim early in the morning and wash it off in the shower a few
hours later. This provides me a far higher testosterone level than
leaving Androgel on all day long. Leaving Testim on all day did not
provide me with any additional increase in testosterone level.


--- In PozHealth@yahoogroups.com, "Richard Weber" <travelchiko05@...>
wrote:
>
> Now what?  Talked to Primary Doc, he is sending me to Endo doc.  What
> does he do, or what will it mean for me?
>
> Really confused on this one and all I want is my energy and libido
> back!!!!
>
> Thanks
>
> Rick
>

Fiber may lower protein linked to heart disease

Fri Mar 31, 11:28 AM ET

NEW YORK (Reuters Health) - A fiber-rich diet may help control levels of a blood
protein linked to an increased risk of heart disease, new research suggests.

In a study of 524 healthy adults, investigators found that those with the
highest fiber intake had lower blood levels of C-reactive protein (CRP) than
those who ate the least fiber. CRP is a marker of ongoing inflammation in the
body, and consistently high levels of this protein have been identified in
previous studies as a risk factor for future heart disease.

The new findings support the general recommendation that adults get 20 to 35
grams of fiber per day, in the form of fruits, vegetables, beans and whole
grains.

Unfortunately, they note in their report in the American Journal of Clinical
Nutrition, the average American consumes only half that amount, lead
investigator Dr. Yunsheng Ma of the University of Massachusetts Medical School
in Worcester and colleagues point out.

For their study, the researchers measured the participants' CRP levels five
times over the course of a year and collected information on diet, exercise
habits and other health factors.

About 18 percent of men and women had elevated CRP levels, above 3 milligrams
per liter of blood. But CRP levels generally dipped as fiber intake increased.
Compared with subjects who ate the least fiber, those who ate the most were 63
percent less likely to have an elevated CRP number.

It did not take a ton of roughage to reap the benefit, the researchers found.
Study participants with the highest fiber intake typically got about 22 grams
per day, or just within the recommended range.

Ongoing, low-level inflammation in the body is thought to contribute to a range
of ills, including clogged arteries and heart disease.

It's not clear why fiber may reduce inflammation, according to Ma's team, but it
may lower cholesterol and blood sugar, both of which can contribute to
inflammation.

"This study," the researchers write, "suggests that a diet high in fiber may
play a role in reducing inflammation and, thus, the risk of cardiovascular
disease and diabetes."

In addition, both of the main forms of fiber, soluble and insoluble, were
related to lower CRP levels. Soluble fiber is found in foods like oatmeal,
beans, berries and apples, while whole grains and many vegetables are good
sources of insoluble fiber.

All of these foods, the study authors write, should become the "foundation of
America's diet to combat heart disease and diabetes."

SOURCE: American Journal of Clinical Nutrition, April 2006.

http://news.yahoo.com/s/nm/20060331/hl_nm/fiber_protein_dc

Epididymal Cysts are common and can get much larger than your's is.

Also called a Spermatocele, they are caused by a back-up of sperm in
a tiny duct, thought to be caused by a blockage. They have no known
association with any medication, nor can they be treated with
medication.

--- In PozHealth@yahoogroups.com, Dmcavi@... wrote:
>
> I have just been diagnosed as having and epidiymal cyst on my
right
> testicle, fairly large 28 x 17 mm.  Does any one of you with HIV
have any  experience
> with this and its possible connection to HIV or treatment
(including  anabolic
> steroids)? I see on the web that generally no action is required
but it  can
> be surgically removed or aspirated if it is painful or continues
to  grow.
> There is pain and  some risk of infection associated with
treatment.
> Right now I do feel some discomfort since my testicle is not
really fully
> descended anyway, probably as the result of a hernia operation
when I was   two
> months old.  Thanks for any information that you can provide,
including  the
> name of a good surgical urologist in NYC?
>

Now what?  Talked to Primary Doc, he is sending me to Endo doc.  What
does he do, or what will it mean for me?

Really confused on this one and all I want is my energy and libido
back!!!!

Thanks

Rick

I had one of these medical exams a few years ago to determine if I can continue being on disability. It was not fun. But I have multiple drug resistance and that helped me make a case. I do not know what would have happened if my viral load had been undetectable. I also brought my pill box with me!

 

click here
Does an Independent Medical Exam Mean They Might Cancel My Long-Term Disability?
I'm a 50-year-old HIVer with a CD4 count of 70 and an undetectable viral load. I've been on long-term disability for eight years. Recently, my long-term disability carrier said it was reviewing my disability claim, and asked me to provide something called an IME (Independent Medical Examination). I loved my job and I miss it, but I'm just not healthy enough to return to work. What if this IME is just the first step toward canceling my disability claim?

 

Regards,


Nelson Vergel
powerusa dot org


"The great tragedy of life is not that people set their sights too high and fail to achieve their goals but they set their sights too low and do."
Michelangelo

People with HIV also have a reduced, or nearly non-existant,
response to LHRH (Leutenizing Hormone Releasing Hormone) the
releasing hormone for testosterone.

These systems use the same signalling  process, from cell receptor
to specific RNA stimulation, which fragments of HIV interferes with
in immune cells, even uninfected immune cells. The performance of
these signalling systems is somewhat improved when HIV viral load is
highly supressed.

--- In PozHealth@yahoogroups.com, PoWeRTX@... wrote:
>
>
> 1: _AIDS._ (javascript:AL_get(this, 'jour', 'AIDS.');)  2006 Apr
> 4;20(6):855-62.
>
> (http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?
PrId=3159&uid=16549969&db=PubMed&url=http://meta.wkhealth.com/pt/pt-
core/template-journal/lwwgateway/
> media/landingpage.htm?an=00002030-200604040-00009)
> Growth hormone secretion among HIV  infected patients: effects of
gender,
> race and fat  distribution.
>
> _Koutkia  P_
> (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?
db=PubMed&cmd=Search&itool=PubMed_Abstract&term="Koutkia+P"[Author])
, _Eaton  K_
> (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?
db=PubMed&cmd=Search&itool=PubMed_Abstract&te
> rm="Eaton+K"[Author]) , _You  SM_
> (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?
db=PubMed&cmd=Search&itool=PubMed_Abstract&term="You+SM"[Author]) ,
_Breu
> J_
> (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?
db=PubMed&cmd=Search&itool=PubMed_Abstract&term="Breu+J"[Author]) ,
_Grinspoon  S_
> (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?
db=PubMed&cmd=Search&itool=PubMed_Abstract&term="Grins
> poon+S"[Author]) .
>
> From the aMassachusetts General Hospital Program in  Nutritional
Metabolism
> and Neuroendocrine Unit, Harvard Medical School, Boston,
Massachusetts, USA
> bGeneral Clinical Research Center, Massachusetts Institute of
Technology,
> Cambridge, Massachusetts, USA.
>
> OBJECTIVE:: To determine the  effects of gender, race, and fat
redistribution
> on growth hormone (GH) secretory  patterns in HIV-infected
patients. DESIGN::
> We investigated GH responses to  growth hormone releasing hormone
(GHRH) +
> arginine stimulation testing in  HIV-infected subjects with fat
redistribution,
> comparing HIV-infected males (n =  139) and females (n = 25) to
non
> HIV-infected male (n = 25) and female (n = 26)  control subjects
similar in age, body
> mass index and race. METHODS:: A standard  GHRH + arginine
stimulation test
> [GHRH 1 mug/kg and arginine 0.5 g/kg (maximum  dose 30 g)] was
performed, and fat
> redistribution was assessed by anthropometry.  RESULTS:: HIV-
infected women
> had significantly higher peak GH in response to  GHRH + arginine
(36.4 +/- 7.3
> versus 18.9 +/- 2.0 ng/ml; P = 0.003) and GH area  under curve
(AUC) (2679 +/-
> 593 versus 1284 +/- 133 (mg-min)/dl, P < 0.001)  compared to HIV-
infected men.
> Among men, a cutoff of 7.5 ng/ml for peak GH  response on the GHRH
+ arginine
> test achieved good specificity and sensitivity  and optimally
separated the
> HIV and control groups (e.g., the failure rates were  37% versus
8%; P = 0.004,
> respectively). Among women, no specific cutoff could  be
determined to
> separate the HIV-infected and control subjects. Non-Caucasians
demonstrated a
> higher GH AUC response compared to Caucasians, among the  HIV-
infected male
> subjects. In stepwise regression modeling waist-to-hip ratio  was
most significantly
> related to peak GH in response to GHRH + arginine in  HIV-infected
men.
> CONCLUSIONS: HIV-infected men with fat  redistribution have
significantly reduced GH
> peak responses and increased  failure rates to standardized GH
stimulation
> testing in comparison to healthy  male control subjects and to HIV-
infected
> women of similar age and body mass  index. GH secretion is related
to gender and
> race in HIV-infected  patients.
>
>
> Regards,
>
>
> Nelson Vergel
> powerusa dot  org
>
>
> "The great tragedy of life is not that people set their sights
too high and
> fail to achieve their goals but they set their sights too low and
do."
> Michelangelo
>

Triamcinolone (aka Kenalog, Kenaject, etc) reduces the growth rate
of fibroblasts, the cells which create scar tissue.

Triamcinolone also inhibits, and can often reverse, the process
which creates granulomas, white cells forming a hard clump in an
auto-immune process.

Thus Trimacinolone can reduce scarring and lumps formed during
healing, and even reduce existing scar tissue and granulomas.


--- In PozHealth@yahoogroups.com, WEBcfm@... wrote:
>
> Hi,
> I think I read a posting on here, not that long ago about someone
getting
> cortisone shots into the lumpy areas caused by sculptra
injections.  I was
> wondering if this was like Kenalog (sp?) shots that I had years
ago to reduce some
> scar tissue on my chest.  The plastic surgeon who did my Sculptra
treatments is
> pretty inexperienced.  I had to go to someone locally to get
financial help
> from a local AIDS org to help pay for it.
> On the right side of my face, the crease that is the "laugh line"
seems to be
> raised up, and I feel the hard lumps along the line.  I massaged
it as I was
> told to do after the applications. For some reason that area just
seemed to
> become raised up from the rest of my face.  Is that the product in
there, or
> collagen that it made my body manufacture?
> When I told the Dr about cortisone shots being used for the lumps,
he said
> he'd look into it..but I'm wondering if he really knows what the
hell he's
> doing.  He says "I don't know" a lot when I ask questions.
> He gave me seven treatments, and I was SEVERELY wasted.  There was
no fat
> left in my face.  It was basically skin and bone.  So, even with
the lumpy area,
> it's still better than it was.
> If anyone can give me some input on this, I'd really appreciate it.
> thank you,
> Charlie in Connecticut
>

Does anyone know of Plastic Surgeons in the Portland, Oregon/Salem
Oregon area that administers the Sculptra injections?

NATAP http://natap.org/
_______________________________________________

_______________________________________________
NATAP nataphcvhiv mailing list -- nataphcvhiv@...

This is an annoucement-only mailing list.  Do not reply.

To unsubscribe: send a blank email to nataphcvhiv-request@... with a
subject of unsubscribe.


For more information, see http://seven.pairlist.net/mailman/listinfo/nataphcvhiv

_______________________________________________

I found the same thing you did.

I did 3 or 4 initial treatments of NewFill/Sculptra (can't remember
exactly) and then did touch ups twice, one year later and a year after
that.  Especially with the increased cost of Scultra now, I gave up on
it.  It wasn't doing me any much good and it wasn't lasting, so I gave
up on Sculptra and got Bio Alcamid.  It's been permanent.  I've needed
a little more Bio Alcamid but it's just to replace the last of the
Sculptra as it disappears.  If you have access to Bio Alcamid it's
definitely more cost-effective than Sculptra, unless you're getting
the Sculptra free or almost free.

--- In PozHealth@yahoogroups.com, "dadin2u" <dadin2u@...> wrote:
>
> I, also, went through the initial series of treatments (5 over 2
> years) have had 2 touch ups 2 years later and had another early this
> year.  Still not near to the level where I was after the initial 5
> treatments.  Going back for one more "touchup".  Am sure this is not
> working as it should and question the cost effectiveness of
Scuptra.
> Something more permanent might be a better way to go. Am
investigating
> other options.  Any thoughts on the matter would be appreciated.
>

I, also, went through the initial series of treatments (5 over 2
years) have had 2 touch ups 2 years later and had another early this
year.  Still not near to the level where I was after the initial 5
treatments.  Going back for one more "touchup".  Am sure this is not
working as it should and question the cost effectiveness of Scuptra.
Something more permanent might be a better way to go. Am investigating
other options.  Any thoughts on the matter would be appreciated.

I have a number of concerns about this use of tenofovir (Viread) for
"pre-exposure prophylaxis" (PrEP).

First, a number of clinical studies were shut down in countries from
Cameroun to Cambodia. Largely because of ethical concerns such as what kind
of treatment will people receive who participate if they should become
HIV+?  There were a LOT of other issues that were raised but appear to have
been largely ignored. Local communities and stakeholders were more or less
shut out from the process (though this began to improve by the time the
study was being developed in Cambodia).

The study was funded by Gates Foundation and CDC apparently. FHI was
conducting. These are not your typical players in clinical trial design.
I'm all for new players--we need the data....

...but the original studies arose out of ONE study of a few macaques who
seemed to be protected. However, several subsequent studies suggested that
exposure resulted in infection. So the intervention does not appear to work.

Meantime, a recent study of ONLY 6 monkeys showed pretty good protection
but now using TWO drugs, tenofovir/emtricitabine ("Truvada"). I think it
behooves them to reproduce these data in other hands before rushing into
studies.

But presuming it does offer some protection--


At 10:25 AM 3/28/2006, you wrote:
>AIDS Drugs Show Prevention Promise
>
>By MARILYNN MARCHIONE, AP Medical Writer 40 minutes ago
>
>snip...
>Condoms and counseling alone have not been enough —

But they are a lot less expensive....about a nickel. We DEFINITELY need
inexpensive, safe microbicides, no question.

Actually, of course, what we REALLY need is a) a vaccine and a) a CURE.

snip...
>The drugs would only be given to people along with counseling and
>condoms,  . . .

Given? Yes. In a study. After? How would people get them--especially say
sex workers in Cambodia? Would the government pay? CDC? Gates? I doubt it.

Seems to me, this merely opens a brand new, lucrative market to Gilead: get
the drugs into people who are not HIV+.

Yet 3 million men, women and children DIED of AIDS last year lacking this
very kind of drug treatment.


>Expense also could limit use of the drugs. Gilead donated them for the
>studies and sells them in poor countries at cost — 57 cents a pill for
>tenofovir and 87 cents for Truvada, the combination drug. That's more than
>the cost of condoms, available for pennies and donated by the truckload in
>Africa, but often unused.

Often unused--so they can't even get condoms to people---but somehow expect
people that often make less than $1 per day to afford not just 57 cents but
$1.44.

>In the United States, wholesale costs are $417 for a month of tenofovir
>and $650 for Truvada.

Yes. Why?

It's utterly arbitrary. Very damned little to do with costs of R&D...note
that Gilead is ONLY providing the drugs. Not paying a dime for these studies.

Again--I am GLAD to have more public funding of studies. Pharma has dished
out too goddamn many lies and used them to justify absolute RAPE--which as
Part D for Death rolls out will only get worse. The government gave up its
right to negotiate better prices (unlike the VA).

Let alone that these drugs are toxic and have side effects.

And let alone that Gilead has a "celebrity of evil" on its Board of Directors.

None other than that lying, murdering, go to war on lies and botch it
horribly murderer and war criminal, Donald Rumsfeld.
George M. Carter

--- In PozHealth@yahoogroups.com, "Jorge Lallemand" <lacuadra70@...>
wrote:
>
> Hi,
>
> I may be tempted to sell one of my life insurance policies, and
was wondering about a good company that serves the South East  or
Florida.
>
> You help and recommendations will be appreciated
>
> Thanks JL


Good luck with that.  I tried to do it last year and sent my policy
info to Life Settlement Alliance, out of Ft. Lauderdale.  THey tood
weeks to get around to it, and in the end nobody was interested.  I
got no offers at all for it, and I finally let it lapse.

I guess I just wasn't sick enough for anyone to risk buying it.
They want you to die fast so they get their money.

For reference:  I'm 47, have been poz for probalby 20 years, have
about 550-650 T-cells, and a viral load that's usually about 75,000
to 150,000.  But I'm never sick and have never had any HIV-related
illneses.  It was about a $200,000 policy.

By the way-- the guy I worked with was real nice, but I don't think
it was his fault.  They just can't find investors who were willing
to speculate on how long it would take till I'll die.

Hope this helps you, but don't be surprised.  But of course, "your
mileage may vary"....

1st Bird-Flu Vaccine Only Partly Effective

By LAURAN NEERGAARD, AP Medical Writer 1 hour, 12 minutes ago

WASHINGTON - The nation's first vaccine against bird flu is only modestly
effective, producing apparent protection in slightly over half the people who
receive two mega-dose shots, initial testing shows. The worrisome findings
underscore the urgency of brewing a better vaccine.

The government had signaled that this vaccine had serious flaws even as it
ordered $162 million worth of shots last summer to stockpile in case the bird
flu mutated to spread easily from person to person.

But results of the first human testing, being published Thursday in The
New England Journal of Medicine, show the extent of the problem: The vaccine
sparked a protective immune response in disappointingly few people — 54 percent
of those who got two shots, 28 days apart, of the highest dose.

Regular winter flu shots, in contrast, protect 75 percent to 90 percent of young
healthy people, the same group that first tested the experimental bird-flu
vaccine. The elderly typically fare worse; how they respond to the bird flu
shots still is being analyzed.

The results weren't too surprising, said lead researcher Dr. John Treanor of the
University of Rochester. Humans have never been exposed to the deadly bird-flu
strain called H5N1, and it takes the immune system awhile to ramp up to fight
unique types of influenza.

The good news: The vaccine seems safe even at doses 12 times stronger than are
used in the regular winter flu shot. The main side effect was pain at the site
of the injection.

Researchers are giving the study's 451 volunteers a third dose, to see if that
spurs more protection. More promising are other studies under way that add
immune-enhancing chemicals to the shots to try to boost their power, in hopes
people could be protected with lower doses.

"We have a long way to go," acknowledged Dr. Anthony Fauci, infectious disease
chief at the
National Institutes of Health, which funded the research.

Indeed, because each shot requires such a high dose, the government's vaccine
stockpile contains enough for just 4 million people, far below its initial goal
of 20 million. Those shots would be reserved for health care providers and
workers in flu vaccine factories if a human epidemic of H5N1 began any time
soon, Fauci said.

The world's vaccine factories are now brewing regular flu shots for next winter.
They would make only bird-flu vaccine if a pandemic began. But at these high
doses, the maximum that could be produced would fully immunize just 75 million
people — 1.25 percent of the world's population — half of whom wouldn't be
adequately protected, Mayo Clinic flu specialist Dr. Gregory Poland wrote in an
accompanying editorial.

Still, "my impression is we are better off having stockpiled this vaccine than
none," said Dr. William Schaffner of Vanderbilt University, a member of an
independent panel that closely monitored the shots' safety during this first
human testing.

"My concern is the public will see (the findings) as the jar half empty," he
said, adding that he preferred that it be viewed as "the first strong step in a
long journey."

More than 180 people worldwide, mostly in Asia, are known to have been infected
with the H5N1 virus since 2003; more than 100 of them have died. Virtually all
were infected by close contact with sick poultry. But flu viruses are prone to
genetic mutations, and as H5N1 is now rapidly continent-hopping via migrating
birds, there is increasing fear that it may eventually become easily spread from
person-to-person, sparking a global epidemic.

Scientists don't know how much of an immune response — the creation of
infection-fighting antibodies — a vaccine must prompt to protect people against
bird flu. So in this first human study, Treanor and colleagues tested whether
the H5N1 vaccine would prompt as much antibody protection as do regular winter
flu shots.

Those annual flu shots contain 15 micrograms of antigen, the key element. For
the H5N1 vaccine, it took two shots that each contained 90 micrograms of antigen
to spur a protective immune response in slightly over half of recipients,
Treanor found.

However, 70 percent of recipients had a slightly lower immune response — and
scientists couldn't say whether they might have some protection against bird
flu.

"Our guess about what will be a protective response may be very conservative,"
Treanor cautioned.

Vaccine manufacturers Sanofi-Pasteur and Chiron Corp. now are adding
immune-enhancing compounds, called alum and MF59 respectively, to the
experimental vaccine in hopes they would spark protection with doses closer to
15 micrograms, thus stretching limited supplies. Pilot studies are optimistic;
Fauci said results may come in the fall.

Further complicating matters: This first H5N1 vaccine is already outdated, based
on a version of the virus culled in Vietnam in 2004. Scientists now are creating
a vaccine based on a slightly different Indonesian version that emerged last
year; they don't yet know how much protection the older vaccine would spur
against the newer virus.

http://news.yahoo.com/s/ap/20060330/ap_on_he_me/bird_flu_vaccine